Dr. Reddy's Laboratories (RDY) Earnings Date, Estimates & Call Transcripts $79.67 -0.13 (-0.16%) (As of 10/18/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateOct. 25EstimatedActual EPS (Jul. 27) $1.00 Missed By -$0.10 Consensus EPS (Jul. 27) $1.10 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRDY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RDY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIIntrigued by massive crypto wins - but too afraid to take the risk? Are you intrigued by the massive wins cryptocurrencies can bring in, but too afraid to take the risk? After all… There's no denying trading Bitcoin and other Cryptocurrencies are some of the most high-risk trades you can place. But what if there was a way to target those massive gains, without even touching a single risky coin? I'm talking about gains as big as… Thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! Click here for a FREE workshop and discover one trader’s $213,000 real-money trade! Dr. Reddy's Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.71$0.71$0.71Q2 20241$0.88$0.88$0.88Q3 20241$0.87$0.87$0.87Q4 20241$0.86$0.86$0.86FY 20244$3.32$3.32$3.32Q1 20251$1.10$1.10$1.10Q2 20251$0.99$0.99$0.99Q3 20251$1.00$1.00$1.00Q4 20251$1.00$1.00$1.00FY 20254$4.09$4.09$4.09Q1 20261$1.01$1.01$1.01Q2 20261$1.00$1.00$1.00Q3 20261$1.01$1.01$1.01Q4 20261$1.04$1.04$1.04FY 20264$4.06$4.06$4.06Q1 20271$0.95$0.95$0.95Q2 20271$0.78$0.78$0.78RDY Earnings Date and InformationDr. Reddy's Laboratories last released its quarterly earnings results on July 27th, 2024. The reported $1.00 EPS for the quarter, missing the consensus estimate of $1.10 by $0.10. The business had revenue of $919.80 million for the quarter, compared to analyst estimates of $861.68 million. Dr. Reddy's Laboratories has generated $4.03 earnings per share over the last year ($4.03 diluted earnings per share) and currently has a price-to-earnings ratio of 19.9. Earnings for Dr. Reddy's Laboratories are expected to grow by 0.49% in the coming year, from $4.11 to $4.13 per share. Dr. Reddy's Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 25th, 2024 based off prior year's report dates.Read More Dr. Reddy's Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/25/2024(Estimated)------- 7/27/2024Q1 2025$1.10$1.00($0.10)$1.00$861.68 million$919.80 million5/7/2024Q4 2024$0.86$0.94+$0.08$0.94$825.20 million$850.00 million1/31/2024Q4 2023$0.88$0.99+$0.11$0.99$827.81 million$867.00 million 10/27/2023Q2 2024$0.88$1.07+$0.19$1.07$825.94 million$832.16 million7/26/2023Q1 2024$0.71$1.03+$0.32$1.03$790.67 million$820.20 million5/10/2023Q4 2023$0.57$0.70+$0.13$0.70$763.37 million$766.00 millionUnlock the Secret to Earning Consistent Income from Stocks Under $30! (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈1/25/2023Q3 2023$0.60$0.91+$0.31$0.91$769.25 million$818.00 million10/28/2022Q2 2023$0.59$0.82+$0.23$0.82$763.28 million$775.00 million7/28/2022Q1 2023$0.58$0.90+$0.32$0.90$767.00 million$660.00 million5/19/2022Q4 2022-$0.53+$0.53$0.99-$717.00 million1/28/2022Q3 2022-$0.57+$0.57$0.57-$715.00 million10/29/2021Q3 2021$0.56$0.80+$0.24$0.80-$777.00 million7/27/2021Q2 2021$0.55$0.46($0.09)$0.46$685.22 million$662.00 million5/13/2021Q1 2021$0.51$0.46($0.05)$0.46-$646.00 million 1/29/2021Q3 2021-$0.41+$0.41$0.80-$675.00 million10/28/2020Q3 2020$0.50$0.62+$0.12$0.62-$666.00 million 7/29/2020Q2 2020$0.42$0.46+$0.04$0.46-$585.00 million 5/20/2020Q1 2020$0.49$0.61+$0.12$0.61$552.28 million$588.00 million 1/27/2020Q3 2020-$0.40+$0.40$1.28-$614.00 million11/1/2019Q2 2020-$0.93+$0.93$0.93-$680.00 million Dr. Reddy's Laboratories Earnings - Frequently Asked Questions When is Dr. Reddy's Laboratories's earnings date? Dr. Reddy's Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 25th, 2024 based off last year's report dates. Learn more on RDY's earnings history. Did Dr. Reddy's Laboratories beat their earnings estimates last quarter? In the previous quarter, Dr. Reddy's Laboratories (NYSE:RDY) missed the analysts' consensus estimate of $1.10 by $0.10 with a reported earnings per share (EPS) of $1.00. Learn more on analysts' earnings estimate vs. RDY's actual earnings. How much revenue does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded annual revenue of $288.51 billion. How much profit does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded net income of $668 million. RDY has generated $4.03 earnings per share over the last four quarters. What is Dr. Reddy's Laboratories's price-to-earnings ratio? Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 19.92 and a forward price-to-earnings ratio of 19.38. The price/earnings-to-growth ratio is 1.73. What is Dr. Reddy's Laboratories's EPS forecast for next year? Dr. Reddy's Laboratories's earnings are expected to grow from $4.11 per share to $4.13 per share in the next year, which is a 0.49% increase. ` More Earnings Resources from MarketBeat Related Companies Takeda Pharmaceutical Earnings Date BioNTech Earnings Date BeiGene Earnings Date Moderna Earnings Date Teva Pharmaceutical Industries Earnings Date Ginkgo Bioworks Earnings Date Genmab A/S Earnings Date Summit Therapeutics Earnings Date Viatris Earnings Date Vaxcyte Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Taiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth? This page (NYSE:RDY) was last updated on 10/20/2024 by MarketBeat.com Staff From Our PartnersAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredHave you heard of Donald Trump’s Project Crypto?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredDon’t Buy Another Stock Until Reading This…Buying stocks in today's market is a gamble… Unless you're using the right proven strategy! During my up...Unstoppable Prosperity | SponsoredElon exposes Last Election plotI know most people will ignore this dire and urgent warning. They’ll say it can’t happen here, not in America.Porter & Company | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Dr. Reddy's Laboratories Limited You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.